Dupont Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Dupont Capital Management's DGX Position: Q3 2023 in Review
Dupont Capital Management sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 2,266 shares — an estimated $319K sold.
Dupont Capital Management first reported a position in DGX in Q4 2016 and held it in 27 quarters. The position peaked at $2.32M in Q2 2017. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.
- Dupont Capital Management reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
- Dupont Capital Management sold 2,266 Quest Diagnostics shares in Q3 2023, an estimated $319K.
- Dupont Capital Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 27 quarters.
- Dupont Capital Management's Quest Diagnostics position peaked at $2.32M in Q2 2017.
- 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.
Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.